208
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Relationship between attitudes toward the effectiveness of vaccine, concerns about adverse reactions, and proactively taking SARS-Cov-2 vaccine for family among medical workers in Taizhou, China

, ORCID Icon, , & ORCID Icon
Pages 269-275 | Received 11 Nov 2021, Accepted 07 Dec 2021, Published online: 19 Dec 2021

References

  • Haas E, Angulo F, McLaughlin J, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–1829.
  • Palacios R, Batista A, Albuquerque C, et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study. Lancet. 2021.
  • Dubé E, Laberge C, Guay M, et al. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9(8):1763–1773.
  • Quinn SC, Jamison AM, An J, et al. Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: results of a national survey of White and African American adults. Vaccine. 2019;37(9):1168–1173.
  • Reno C, Maietti E, Di Valerio Z, et al. Vaccine hesitancy towards COVID-19 vaccination: investigating the role of information sources through a mediation analysis. Infect Dis Rep. 2021;13(3):712–723.
  • Chu H, Liu S. Integrating health behavior theories to predict American’s intention to receive a COVID-19 vaccine. Patient Educ Couns. 2021;104(8):1878–1886.
  • Wang J, Zhang Y, Long S, et al. Non-EPI vaccine hesitancy among Chinese adults: a cross-sectional study. Vaccines (Basel). 2021;9(7):772.
  • Hwang J. Health information sources and the influenza vaccination: the mediating roles of perceived vaccine efficacy and safety. J Health Commun. 2020;25(9):727–735.
  • Zhang M, Zhang T, Shi G, et al., Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China. Expert Rev Vaccines. 2021;20(7): 891–898.
  • Robins J, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology. 1992;3(2):143–155.
  • Pearl J. Interpretation and identification of causal mediation. Psychol Methods. 2014;19(4):459–481.
  • Baron R, Kenny D. The moderator-mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–1182.
  • MacKinnon D, Fairchild A, Fritz M. Mediation analysis. Annu Rev Psychol. 2007;58(1):593–614.
  • Preacher K, Hayes A. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40(3):879–891.
  • MacKinnon D, Lockwood C, Hoffman J, et al. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7(1):83–104.
  • Muller D, Judd C, Yzerbyt V. When moderation is mediated and mediation is moderated. J Pers Soc Psychol. 2005;89(6):852.
  • Valeri L, VanderWeele T. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013;18(2):137–150.
  • Zhu J, Zhang M, Chien C, et al. Sex differences in adverse reactions to an inactivated SARS-CoV-2 vaccine among medical staff in China. Front Med (Lausanne). 2021;8:731593.
  • Mc Conalogue D, Verle N, Ellis H, et al. Influenza and vaccination: beliefs and practices of local authority staff. Occup Med (Lond). 2019;69(6):445–452.
  • Palacios R, Patiño E, de Oliveira P, et al. Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (inactivated) vaccine manufactured by sinovac - PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):853.
  • Folegatti P, Ewer K, Aley P, et al. Oxford COVID vaccine trial group. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467–478.
  • King C, Leask J. The impact of a vaccine scare on parental views, trust and information needs: a qualitative study in Sydney, Australia. BMC Public Health. 2017;17(1):106.
  • Larson H, Schulz W, Tucker J, et al. Measuring vaccine confidence: introducing a global vaccine confidence index. PLoS Curr. 2015;7. ecurrents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4.
  • Alduwayghiri E, Khan N. Acceptance and attitude toward COVID-19 vaccination among the public in Saudi Arabia: a cross-sectional study. J Contemp Dent Pract. 2021;22(7):730–734.
  • Rabi R, Maraqa B, Nazzal Z, et al. Factors affecting nurses‘ intention to accept the COVID-19 vaccine: a cross-sectional study. Public Health Nurs. 2021;38(5):781–788.
  • Patel M, Thornburg N, Stubblefield W, et al. Change in antibodies to SARS-CoV-2 over 60 days among health care personnel in Nashville, Tennessee. JAMA. 2020;324(17):1781–1782.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.